John Patience's most recent trade in Biodesix Inc was a trade of 22,874 Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 22,874 | 407,486 | - | - | Common Stock | |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 22,874 | 45,747 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 68,621 | 68,621 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 42,010 | 42,010 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 46,686 | 384,612 | - | - | Common Stock | |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 46,686 | 0 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Patience John | Director | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 03 Dec 2024 | 200,000 | 653,224 (1%) | 0% | 1.6 | 314,000 | Common Stock |
| Biodesix Inc | John Patience | Director, Chairman | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 05 Nov 2024 | 75,000 | 2,153,298 | - | 1.4 | 103,710 | Common Stock |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 217,400 | 4,829,611 | - | - | Common Stock | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 46,686 | 46,686 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | John Patience | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2024 | 5,435 | 0 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Accelerate Diagnostics Inc | John Patience | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 66,667 | 66,667 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 5,435 | 5,435 | - | - | Series A Non-Voting Convertible Preferred Stock | |
| Accelerate Diagnostics Inc | John Patience | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 16,666 | - | - | Common Stock Warrants (right to buy) | |
| Accelerate Diagnostics Inc | Patience John | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 453,224 (0%) | 0% | - | Common Stock | |
| Biodesix Inc | Patience John | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 105,389 | 134,262 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 61,728 | 4,612,211 | - | 1.6 | 99,999 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 236,842 | 236,842 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | John Patience | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2023 | 78,947 | 78,947 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 28,873 | 28,873 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 4,878 | 150,711 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 62,500 | 145,833 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 21 Nov 2022 | 1,739,130 | 4,550,483 | - | 1.2 | 2,000,000 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 75,949 | 75,949 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 83,333 | 83,333 | - | - | Restricted Stock Units | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 07 Apr 2022 | 279,329 | 337,926 | - | 1.8 | 499,999 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 30 Dec 2021 | 137,931 | 2,078,298 | - | 4.4 | 600,000 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 4.35 per share. | 30 Dec 2021 | 22,988 | 52,988 | - | 4.4 | 99,998 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 6.18 per share. | 23 Nov 2021 | 10,000 | 1,940,367 | - | 6.2 | 61,753 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 6.34 per share. | 18 Nov 2021 | 9,497 | 1,930,367 | - | 6.3 | 60,220 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 30 Sep 2021 | 21,702 | 4,365,585 (7%) | 0% | 7.7 | 166,671 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 8.04 per share. | 19 Aug 2021 | 8,396 | 1,920,870 | - | 8.0 | 67,490 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Purchase of securities on an exchange or from another person at price $ 7.12 per share. | 17 Aug 2021 | 1,604 | 1,912,474 | - | 7.1 | 11,416 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 34,385 | 34,385 | - | - | Stock Options (Right to buy) | |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 35,168 | 35,168 | - | - | Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 09 Apr 2021 | 21,701 | 4,343,883 (7%) | 0% | 7.7 | 166,664 | Common Stock |
| Accelerate Diagnostics Inc | John Patience | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.68 per share. | 19 Feb 2021 | 21,701 | 4,322,182 (7%) | 0% | 7.7 | 166,664 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 35,157 | 1 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.83 per share. | 07 Dec 2020 | 35,157 | 35,157 | - | 6.8 | 240,122 | Common Stock |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 23,440 | 11,718 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | John Patience | Director, Ten Percent Owner, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.83 per share. | 07 Dec 2020 | 23,440 | 58,597 | - | 6.8 | 160,095 | Common Stock |